Ecstasy and the Dorsomedial Hypothalamus

狂喜与下丘脑背内侧

基本信息

项目摘要

DESCRIPTION (provided by applicant): MDMA (ecstasy, 3, 4-methylenedioxymethamphetamine) is a popular drug of abuse with rising use being coupled with increasing reports of medical complications and emergency department visits. MDMA abuse has been linked with hyperthermia, cardiovascular collapse, renal failure and death. Previous studies have shown that MDMA's toxic effects are dependent on the activation of the hypothalamic-pituitary-thyroidadrenal axis and the sympathetic nervous system. Activation of these systems likewise occurs during stress where it appears to be dependent on the activation of neurons in the region of the dorsomedial hypothalamus (DMH). Many of the physiologic effects of MDMA can be replicated by chemical stimulation of neurons in the area of the DMH. These effects include increases in heart rate (HR), mean arterial pressure (MAP), temperature, plasma ACTH and locomotor activity. Along with physiologic similarities, the DMH is an anatomic area rich in norepinephrine and dopamine, both integral in mediating MDMA's effects. Based on these findings, it is our central hypothesis that MDMA causes acute increases in norepinephrine and dopamine release in the DMH activating key effector sites involved in the stimulation of the HPTA axis and the sympathetic nervous system. Ultimately activation of these systems causes hyperthermia, tachycardia, hypertension, and cutaneous vasoconstriction, effects which are amplified in a warm environment. Specific Aims: The specific aims of this grant will (1) Characterize the role of neurons in the DMH in mediating MDMA's activation of neuroendocrine and sympathetic nervous systems in both normal and elevated ambient temperatures, (2) Identify key brain regions whose activation by MDMA is mediated through the DMH (3) Characterize changes in catecholamines in the DMH resulting from administration of MDMA. These studies will be performed in freely moving conscious rats using techniques of; microinjection, biotelemetric physiologic monitoring, radioimmunoassay for the markers of neuroendocrine activation, HPLC analysis of serum and brain catecholamines, microdialysis and C-fos immunohistochemistry. Relevance: The research proposed in this application is significant because through the understanding of the central pathways responsible for MDMA's toxic effects we will come closer to the development of improved treatment strategies for persons abusing MDMA as well as others stimulants. Goals: Through a comprehensive training program including didactic course work and mentored research training it is the goal of the proposal to provide the necessary training and education for the applicant's development as an independent investigator.
描述(由申请人提供): MDMA(摇头丸,3,4-亚甲二氧基甲基苯丙胺)是一种流行的滥用药物,随着使用量的增加,医疗并发症和急诊就诊的报告也在增加。MDMA滥用与体温过高、心血管衰竭、肾衰竭和死亡有关。以往的研究表明,MDMA的毒性作用依赖于下丘脑-垂体-甲状腺-肾上腺轴和交感神经系统的激活。这些系统的激活同样发生在应激期间,其中它似乎依赖于背内侧下丘脑(DMH)区域中的神经元的激活。MDMA的许多生理效应可以通过化学刺激DMH区域的神经元来复制。这些影响包括心率(HR)、平均动脉压(MAP)、体温、血浆ACTH和自发活动的增加。沿着生理学上的相似性,DMH是一个富含去甲肾上腺素和多巴胺的解剖区域,两者都是介导MDMA效应的组成部分。基于这些发现,我们的中心假设是MDMA引起DMH中去甲肾上腺素和多巴胺释放的急性增加,激活参与刺激HPTA轴和交感神经系统的关键效应位点。这些系统的最终激活导致体温过高、心动过速、高血压和皮肤血管收缩,这些效应在温暖的环境中被放大。具体目标:该基金的具体目标是:(1)描述DMH中神经元在正常和升高的环境温度下介导MDMA激活神经内分泌和交感神经系统中的作用;(2)确定MDMA激活通过DMH介导的关键脑区;(3)描述MDMA给药后DMH中儿茶酚胺的变化。这些研究将在自由活动的清醒大鼠中进行,使用的技术包括:显微注射、生物遥测生理监测、神经内分泌激活标志物的放射免疫测定、血清和脑儿茶酚胺的HPLC分析、微透析和C-fos免疫组织化学。相关性:本申请中提出的研究具有重要意义,因为通过了解MDMA毒性作用的中枢途径,我们将更接近于为滥用MDMA和其他兴奋剂的人制定更好的治疗策略。目标:通过一个全面的培训计划,包括教学课程和指导研究培训,该提案的目标是为申请人作为独立研究者的发展提供必要的培训和教育。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANIEL E RUSYNIAK其他文献

DANIEL E RUSYNIAK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANIEL E RUSYNIAK', 18)}}的其他基金

CNS circuitry and receptors mediating the effects of MDMA
中枢神经系统回路和受体介导 MDMA 的作用
  • 批准号:
    8263783
  • 财政年份:
    2010
  • 资助金额:
    $ 18.13万
  • 项目类别:
CNS circuitry and receptors mediating the effects of MDMA
中枢神经系统回路和受体介导 MDMA 的作用
  • 批准号:
    8081087
  • 财政年份:
    2010
  • 资助金额:
    $ 18.13万
  • 项目类别:
CNS circuitry and receptors mediating the effects of MDMA
中枢神经系统回路和受体介导 MDMA 的作用
  • 批准号:
    8655527
  • 财政年份:
    2010
  • 资助金额:
    $ 18.13万
  • 项目类别:
CNS circuitry and receptors mediating the effects of MDMA
中枢神经系统回路和受体介导 MDMA 的作用
  • 批准号:
    8460974
  • 财政年份:
    2010
  • 资助金额:
    $ 18.13万
  • 项目类别:
Ecstasy and the Dorsomedial Hypothalamus
狂喜与下丘脑背内侧
  • 批准号:
    7391572
  • 财政年份:
    2006
  • 资助金额:
    $ 18.13万
  • 项目类别:
Ecstasy and the Dorsomedial Hypothalamus
狂喜与下丘脑背内侧
  • 批准号:
    7015479
  • 财政年份:
    2006
  • 资助金额:
    $ 18.13万
  • 项目类别:
Ecstasy and the Dorsomedial Hypothalamus
狂喜与下丘脑背内侧
  • 批准号:
    7797582
  • 财政年份:
    2006
  • 资助金额:
    $ 18.13万
  • 项目类别:
Ecstasy and the Dorsomedial Hypothalamus
狂喜与下丘脑背内侧
  • 批准号:
    7596466
  • 财政年份:
    2006
  • 资助金额:
    $ 18.13万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 18.13万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了